Abstract
Six hundred ninety-two clinical isolates of Staphylococcus aureus were collected from blood cultures of 692 patients in 15 Israeli hospitals over a two year period. Antibiotic sensitivity was tested by the standard disk diffusion technique. Of these isolates, 41.6% were methicillin-resistant (MRSA). All 288 MRSA isolates were sensitive to vancomycin and pristinomycin; 98.6% were sensitive to fucidine; 97.9% to imipenem; 79% to rifampicin; 63.6% to amikacin; 54.5% to augmentin; 36.4% to clindamycin; 12.6% to ciprofloxacin; 11.9% to cotrimoxazole and ofloxacin; 10.5% to gentamicin; 9.8% to erythromycin; and 8.4% to norfloxacin. Phage typing was determined by using the international set of phages. All the isolates that were sensitive to Group I phages, and 91.8% of those sensitive to Group II phages, were sensitive to methicillin. Of the isolates that were sensitive to Group III phages, 79.2% were methicillin-resistant and 72.4% of the latter were sensitive to phages 75/85. Of the isolates that were sensitive to Group III and miscellaneous phages, 50.7% were methicillin-resistant and 71% of the latter were sensitive to phages 75/85 as well.
Similar content being viewed by others
References
Acar J.F. and Goldstein F.W. (1986): Disk Susceptibility Test. In: Antibiotics in Laboratory Medicine, edited by Lorian, V. Williams & Wilkins, New York.
Acar J.F., Courvalin P. and Chabbert Y.A. (1970): Methicillin-resistant Staphylococcemia: bacteriological failure of treatment with cephalosporine -Antimicrob. Agents Chemother. 197: 280–285.
Blair J.E. and Williams R.E.Q. (1961): Phage typing of Staphylococci - Bull. W.H.O. 24: 771–784.
Brumfitt W. and Hamilton-Miller J. (1989): Methicillin-resistant Staphylococcus aureus - N. Eng. J. Med. 320: 1188–1196.
Garrod L.P., Lambert H.P. and O'Grady F. (1981): In: Antibiotic and Chemotherapy, Churchill Livington, Edinburgh, p. 235.
Jessen O., Rosendal K., Bulow P., Faber Y. and Eriksen K.R. (1969): Changing Staphylococci and Staphylococcal infections - N. Eng. J. Med. 281: 627–635.
Kayser F.H. and Mak T.M. (1972): Methicillin-resistant Staphylococci - Am. J. Med. Sci. 264: 197–205.
Milatovic D. (1986): Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: Are there alternatives? - Eur. J. Clin. Microbiol. 5: 689–692.
Richmond M.H. (1965): Wild-type variants of exopenicillinase from Staphylococcus aureus -Biochemistry J. 94: 584–593.
Samra Z, Borin M. and Lazarovitch T. (1988): Phage typing and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus - Isr. J. Med. Sci. 24: 386.
Sabath L.D. (1982): Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus - Ann. Int. Med. 97: 339–344.
Sheagren J.N. (1984): Staphylococcus aureus: The persistent pathogen - N. Eng. J. Med. 310: 1369–1373.
Sorrel T. C., Packham D.R., Shankr S.J., Foldes M. and Munro R. (1982): Vancomycin therapy for methicillin-resistant Staphylococcus aureus - Ann. Int. Med. 97: 344–350.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Samba, Z., Gadba, R. Antibiotic susceptibility and phage typing of methicillin-resistant Staphylococcus aureus clinical isolates from blood cultures of 692 patients in 15 Israeli hospitals. Eur J Epidemiol 9, 559–562 (1993). https://doi.org/10.1007/BF00209536
Issue Date:
DOI: https://doi.org/10.1007/BF00209536